Status:
COMPLETED
Evaluation of a Resiliency Intervention for Siblings of Children With Autism Spectrum Disorder (ASD)
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Health Resources and Services Administration (HRSA)
Conditions:
Stress
Eligibility:
All Genders
14-17 years
Phase:
NA
Brief Summary
The proposed research has the following objectives: Based off findings from the "Development of a Resiliency Program for Siblings of Children with Autism Spectrum Disorder" qualitative focus group st...
Detailed Description
This intervention will be a modified version of Dr. Elyse Park's evidence-based 8-week multimodal treatment which is designed to promote adaptation to stress and promotion of resiliency. The program i...
Eligibility Criteria
Inclusion
- Age 14-17 years (inclusive of ages 14 and 17)
- Being the sibling of at least one individual with ASD
- Access to internet or smart phone
- English speaking
Exclusion
- Diagnosis of ASD
- Past year psychiatric hospitalization
- There are no exclusion criteria with respect to ethnicity or socioeconomic status.
Key Trial Info
Start Date :
January 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04369417
Start Date
January 28 2020
End Date
January 1 2021
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02215